Humanitarian Nutrition Local-Sourcing Director

The mandate

The agency wants to reduce ocean lead time for ready-to-use therapeutic food and related nutrition kits by developing regional manufacturers. Current proposals count local peanuts, oil and packaging, but do not connect aflatoxin and microbiological control, milk-powder and premix access, formulation rights, sachet barrier, laboratory capacity, batch release, seasonal raw-material quality, donor eligibility and outbreak surge. The defined problem is an evidence-gated local-sourcing architecture, not emergency corridor command or a transfer of food-safety approval to consultants.

The deliverable is a three-country source design covering ingredient genealogy, seasonal quality, approved formulations, supplier and laboratory capability, sachet and carton supply, production lines, release, donor conditions, cost, inventory bridge and surge response. It includes fifteen site observations, six manufacturer pathways, three ingredient shocks and two demand surges. Product standard-setting, supplier certification, Quality release, tender award, factory management, programme allocation and donor representation are excluded.

Milestone one, at month one, provides the ingredient and pack dependency baseline. Milestone two, at month two, delivers manufacturer and laboratory capability evidence. Milestone three, at month three, completes six source pathways and commercial ranges. Milestone four, at month four, tests seasonal ingredient and packaging shocks. Milestone five, at month five, runs two surge simulations. Milestone six, at month six, submits accepted gates, investment cases and a 180-day mobilisation backlog.

Acceptance requires Nutrition, Food Safety, Quality, Procurement, donor-compliance and country supply teams to reproduce when each pathway could first deliver released, programme-usable product and why. The architecture must distinguish locally available ingredients from approved, batch-ready inputs and survive aflatoxin rejection, imported-premix delay and doubled demand without inventing release. Sign-off follows trained owners, six evidence-complete pathways and named decisions for every severity-one dependency, not placement of a local purchase order.

The client will provide product standards, recipes and rights, supplier files, ingredient and packaging tests, line and laboratory evidence, audits, release histories, demand and programme calendars, freight and inventory, donor conditions, costs and authorised subject experts. It will secure fifteen observations and fund approved trials. Food Safety and Quality retain technical decisions; Procurement awards suppliers; manufacturers run plants; programmes allocate product; donors determine eligibility.

Why this is external work

Country teams favour speed and local economic benefit, global Quality protects standards and incumbent suppliers defend proven routes. An external director can test regional pathways consistently without selling factory capacity or importing one function’s bias. The required perspective crosses agricultural variability, fortified-food manufacture, flexible packaging, release evidence and humanitarian surge economics.

What you will own

• Map each nutrition product from ingredient and formulation through manufacture, test, release, pack, donor eligibility and programme receipt.
• Test local oil, base crop, milk powder, sugar, premix, emulsifier and packaging for seasonal quality and scalable supply.
• Assess six manufacturers by process control, segregation, hygiene, laboratory, sachet integrity, traceability, release history and surge capability.
• Build first-usable-supply pathways that include technical, audit, trial, release, donor and inventory-bridge clocks.
• Model aflatoxin rejection, premix interruption, sachet shortage and doubled demand across cost, availability and patient consequence.
• Separate local economic value from safe product readiness and document decisions that authorised functions must make.
• Deliver source dossiers, investment ranges, evidence gates, simulation results, owner training and the 180-day mobilisation backlog.

Candidate qualifications

• Directed therapeutic-food, fortified-nutrition or comparable high-risk humanitarian food supply across regional manufacturers.
• Has qualified ingredient, packaging, production and laboratory pathways without weakening aflatoxin, microbiological or release standards.
• Understands therapeutic-food formulations, premix, oil and base-crop variability, sachet barriers, donor conditions and surge planning.
• Can build sourcing recommendations without assuming Food Safety, Quality, donor, tender, factory or programme-allocation authority.
• Has tested local-manufacturing economics against realistic qualification, imported dependencies, seasonal loss and inventory bridge.
• Remains independent of food makers, ingredient traders, packaging converters, laboratories, logistics providers and implementing partners.

Non-negotiables

• Can complete fifteen East African and European observations plus two surge simulations within six months.
• Brings direct therapeutic or fortified-nutrition manufacturing supply; generic food procurement or humanitarian logistics is insufficient.
• Will not sell ingredients, packaging, laboratory, certification, freight, factory capacity or follow-on implementation into the work.
• Accepts Nutrition, Food Safety, Quality, Procurement, manufacturer, donor and programme-allocation decision boundaries.

1. 49 words maximum. Describe a local therapeutic-food source you rejected despite attractive ingredient proximity and cost.
2. 49 words maximum. Which imported dependency most often invalidates a supposedly local nutrition pathway?
3. 49 words maximum. What manufacturer, ingredient, packaging, laboratory or donor relationship could affect your independence?

---